Germinal matrix hemorrhage

Jump to navigation Jump to search
Germinal matrix hemorrhage
eMedicine radio/305 

WikiDoc Resources for Germinal matrix hemorrhage

Articles

Most recent articles on Germinal matrix hemorrhage

Most cited articles on Germinal matrix hemorrhage

Review articles on Germinal matrix hemorrhage

Articles on Germinal matrix hemorrhage in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Germinal matrix hemorrhage

Images of Germinal matrix hemorrhage

Photos of Germinal matrix hemorrhage

Podcasts & MP3s on Germinal matrix hemorrhage

Videos on Germinal matrix hemorrhage

Evidence Based Medicine

Cochrane Collaboration on Germinal matrix hemorrhage

Bandolier on Germinal matrix hemorrhage

TRIP on Germinal matrix hemorrhage

Clinical Trials

Ongoing Trials on Germinal matrix hemorrhage at Clinical Trials.gov

Trial results on Germinal matrix hemorrhage

Clinical Trials on Germinal matrix hemorrhage at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Germinal matrix hemorrhage

NICE Guidance on Germinal matrix hemorrhage

NHS PRODIGY Guidance

FDA on Germinal matrix hemorrhage

CDC on Germinal matrix hemorrhage

Books

Books on Germinal matrix hemorrhage

News

Germinal matrix hemorrhage in the news

Be alerted to news on Germinal matrix hemorrhage

News trends on Germinal matrix hemorrhage

Commentary

Blogs on Germinal matrix hemorrhage

Definitions

Definitions of Germinal matrix hemorrhage

Patient Resources / Community

Patient resources on Germinal matrix hemorrhage

Discussion groups on Germinal matrix hemorrhage

Patient Handouts on Germinal matrix hemorrhage

Directions to Hospitals Treating Germinal matrix hemorrhage

Risk calculators and risk factors for Germinal matrix hemorrhage

Healthcare Provider Resources

Symptoms of Germinal matrix hemorrhage

Causes & Risk Factors for Germinal matrix hemorrhage

Diagnostic studies for Germinal matrix hemorrhage

Treatment of Germinal matrix hemorrhage

Continuing Medical Education (CME)

CME Programs on Germinal matrix hemorrhage

International

Germinal matrix hemorrhage en Espanol

Germinal matrix hemorrhage en Francais

Business

Germinal matrix hemorrhage in the Marketplace

Patents on Germinal matrix hemorrhage

Experimental / Informatics

List of terms related to Germinal matrix hemorrhage

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Germinal matrix hemorrhage is a bleeding into the subependymal germinal matrix with or without subsequent rupture into the lateral ventricle. The microcirculation in this particular area is extremely sensitive to hypoxia and changes in perfusion pressure. It is most frequent before 35 weeks gestation and is typically seen in low birth-weight (<1500g) premature infants.

Germinal matrix hemorrhage (GMH) and intraventricular hemorrhage (IVH) are the most common neurologic injuries in preterm neonates. The brain of a premature infant lacks the ability to autoregulate cerebral blood pressure. Fluctuations in cerebral blood pressure and flow can rupture the primitive germinal matrix vessels or lead to infarction of the metabolically active germinal matrix. The damage can extend into the periventricular white matter, resulting in significant neurologic sequelae, including cerebral palsy, mental retardation, and seizures. A common lesion that characterizes the neuropathology of GMH/IVH is bleeding into the subependymal germinal matrix, with or without subsequent rupture into the lateral ventricle. Sequelae of GMH/IVH include germinal matrix destruction, periventricular hemorrhagic infarction with subsequent encephalomalacia], and posthemorrhagic hydrocephalus. Because maturation of the germinal matrix vasculature occurs in the perinatal period for premature infants, most cases of GMH/IVH occur in the first week of life for these infants. Approximately 50% of cases of GMH/IVH occur in the first day of life. The major risk factors for GMH include a young gestational age, low birth weight, acute amnionitis, and exposure to antenatal steroids for less than 48 hours.

  • Grade 1: Hemorrhage that is confined to the germinal matrix
  • Grade 2: Extension of the hemorrhage into the lateral ventricles without hydrocephalus
  • Grade 3: Ventricular hemorrhage with the presence of associated hydrocephalus
  • Grade 4: Parenchymal hemorrhage

Ultrasound

  • US is the primary modality for both screening and follow-up of GMH/IVH in neonates.
  • Acute subependymal hemorrhage appears as a homogeneous echogenic mass, often in the caudothalamic groove. The hematoma becomes less echogenic over time, beginning with the central portion. Subsequent to eventual clot retraction, a subependymal cyst may develop, or a linear echo may result.
  • Acutely, IVH also appears echogenic. Cerebrospinal fluid (CSF)–blood fluid levels may be observed. When large, the clot forms a cast of the ventricle.

References

  • Enzmann D, Murphy-Irwin K, Stevenson D, Ariagno R, Barton J, Sunshine P (1985). "The natural history of subependymal germinal matrix hemorrhage". Am J Perinatol. 2 (2): 123–33. PMID 3913430.


Template:WikiDoc Sources